Currently, large-scale culturing of embryonic and induced pluripotent stem (ES, iPS) cell lines for use in regenerative medicine and drug discovery applications is a major challenge in biomedical research and the pharmaceutical industry. To overcome this bottleneck, stem cell culture processes must become robust, reproducible, and capable of generating sufficient numbers of cells while still maintaining a stable stem cell phenotype.
Physical passage using specialized stem cell knives, razors, or pipettes to manually section stem cell colonies is widely accepted as the ideal method for propagation of human ES and iPS cell lines. Manual passage of stem cell lines does not involve the use of enzymes, and therefore is thought to better maintain genetic stability of human ES and iPS cells in long-term culture.
Other benefits of manual passage of stem cell cultures include decreased cellular trauma and selective transfer of specific undifferentiated colonies. Scale-up of multiple stem cell lines using manual methods, however, is unattractive because of the high labor cost, tremendous time consumption, lack of automation, and variability of output associated with varying expertise.
Due to the technical demands associated with manual passage, routine passage and expansion of human ES and iPS cell lines is often performed using enzymatic passage. Enzymatic methods using collagenase or trypsin are useful for large-scale expansion and are well suited for automated platforms. Bulk passage using enzymatic methods, however, is highly problematic. Both collagenase and trypsin dissociation result in variable-sized colonies leading to significant inconsistency among cultures. In addition, enzymatic propagation results in significant cellular trauma that may be associated with increased rates of genetic instability.
Cyntellect’s Stem Cell Manager powered by LEAP, a high-throughput, microplate cytometry system, is a series of stem cell management processes including automated physical passage of stem cells, automated embryoid body generation, and purification of specialized cell types derived from stem cells.
The Stem Cell Passage application automates physical passage of stem cell colonies using laser manipulation instead of a mechanical device, enabling a standardized, reproducible method for automated large-scale generation of uniform ES and iPS cultures.
The Stem Cell Passage application uses laser-mediated sectioning of ES and iPS cell cultures to create specific-sized clumps in a sterile closed multiwell plate environment. Clumps of defined size can then be transferred to new culture dishes by simple pipetting. Enzymes are not required for passage using the Stem Cell Passage application. Automated physical passage of ES and iPS cell cultures using the Stem Cell Passage application reduces the labor and time demands associated with manual passage techniques.